Search Login Register

Meningeal Carcinomatosis Summary

Description: Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.

Also Known As: Leptomeningeal Carcinomatosis; Carcinomatoses, Leptomeningeal; Carcinomatoses, Meningeal; Carcinomatosis, Leptomeningeal; Carcinomatosis, Meningeal Show All >>

Networked: 326 relevant articles (44 outcomes, 20 trials/studies) for this Disease

Key Drugs and Agents for Meningeal Carcinomatosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. gefitinib (Iressa) : 7 outcomes in 17 results : FDA 1
  2. Cytarabine (Cytosar-U) : 4 outcomes 1 study in 18 results : FDA 13 Generic
  3. Immunotoxins (Immunotoxin) : 4 outcomes in 6 results : IBA
  4. Methotrexate (Mexate) : 3 outcomes 3 studies in 34 results : FDA 8 Generic
  5. erlotinib (CP 358,774) : 2 outcomes in 10 results : FDA 1
  6. Nimustine : 2 outcomes in 6 results : IBA
  7. Transferrin (beta 2 Transferrin) : 2 outcomes in 2 results : IBA
  8. taxane : 2 outcomes in 2 results : IBA
  9. Gadolinium : 1 outcome 2 studies in 10 results : IBA
  10. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor) : 1 outcome 2 studies in 3 results : IBA
Show All >>

Diseases Related to Meningeal Carcinomatosis

  1. Breast Neoplasms (Breast Cancer)
  2. Neoplasms (Cancer)
  3. Stomach Neoplasms (Stomach Cancer)
  4. Lung Neoplasms (Lung Cancer)
  5. Meningeal Carcinomatosis
Show All >>

Key Therapies for Meningeal Carcinomatosis

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 10 outcomes 5 studies in 76 results
  2. Aftercare (After-Treatment) : 2 outcomes in 8 results
  3. Radiotherapy : 1 outcome 1 study in 16 results
  4. Palliative Care (Palliative Medicine) : 1 outcome 1 study in 4 results
  5. Ventriculoperitoneal Shunt : 1 outcome in 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.